Sorted By:

Relevance


Biopharmaceutical Innovation Benefits Many Sectors of Industry

PhRMA  |  Blog Post

To learn more about the behind the scenes contributions to biopharmaceutical development, watch the full video:  
http://catalyst.phrma.org/biopharmaceutical-innovation-benefits-many-sectors-of-industry

Medicare Monday: 3 Medicare videos

PhRMA  |  Blog Post

5 Things You Might Not Know About Medicare Part DA quick refresher on the Medicare Part D program, how it works and who it benefits .youtube.com/watch?
http://catalyst.phrma.org/medicare-monday-3-medicare-videos

Medicare Monday: Medication Therapy Management in Part D – Another Potential Opportunity for Savings

PhRMA  |  Blog Post

Specifically, the extra Medicare costs associated with poor medication adherence ranged from $49 to $840 per month.
http://catalyst.phrma.org/medicaremonday-medication-therapy-management-in-part-d-another-potential-opportunity-for-savings

Fact Check Friday: The Truth About Negotiation in Medicare Part D

PhRMA  |  Blog Post

Total program costs are 45 percent – or $349 billion – lower than CBO’s initial 10-year projections.
http://catalyst.phrma.org/fact-check-friday-the-truth-about-negotiation-in-medicare-part-d

The U.S.– India Relationship is Full of Opportunities

PhRMA  |  Blog Post

In effect, our government will have the opportunity to measure progress made by India since the last Special 301 report, released while Mr.
http://catalyst.phrma.org/the-us-india-relationship-is-full-of-opportunities

New video: Saving lives and building for the future

PhRMA  |  Blog Post

  Today’s medicines are at the forefront of science with many new treatments taking a targeted approach to attacking underlying causes of disease.
http://catalyst.phrma.org/new-video-saving-lives-and-building-for-the-future

Many Say High Deductibles Make Their Health Law Insurance All but Useless

Access Better Coverage  |  From Our Network

In Chicago, the median deductible is $3,400.
http://www.accessbettercoverage.org/social-news/many-say-high-deductibles-make-their-health-law-insurance-all-but-useless

Medicare Monday: Helping Hypertensive Patients Live Healthier Lives

PhRMA  |  Blog Post

Dawn says Part D empowered her to go to the doctor and get the treatments she needs for high blood pressure, and .com/content.aspx?
http://catalyst.phrma.org/medicare-monday-helping-hypertensive-patients-live-healthier-lives

PhRMA Responds to New York TImes

PhRMA  |  Press Release

According to the American Lung Association, asthma causes about 440,000 hospitalizations, 2.1 million emergency room visits, and about 3,400 deaths a year.
https://www.phrma.org/press-release/phrma-responds-to-new-york-times

Maintaining Appropriate Incentives for Biopharmaceutical Innovation

PhRMA  |  Blog Post

New research by Duke economist Henry Grabowski and others reinforces that patents and data protection are foundational to fostering continued innovation.
http://catalyst.phrma.org/maintaining-appropriate-incentives-for-biopharmaceutical-innovation

Medical Mysteries of the Heart

From Hope To Cures  |  From Our Network

Half of the participants were told to reduce their systolic blood pressure — the top number — to below 120 by using common medications, while the other half aimed for below 140.
http://www.fromhopetocures.org/medical-mysteries-of-the-heart

ICYMI: New Oncology Trend Report Highlights the Future Promise of Innovation

PhRMA  |  Blog Post

As part of our Healthy Outlook: Conquering Cancer in the 21st Century blog series, we wanted to highlight a new .imshealth.com/portal/site/imshealth/menuitem.c76283e8bf81e98f53c753c71ad8c22a/?
http://catalyst.phrma.org/icymi-new-oncology-trend-report-highlights-the-future-promise-of-innovation

Time to enforce the rules that protect American ideas, brands and inventions

PhRMA  |  Blog Post

Earlier today, PhRMA joined organizations representing every sector of America’s knowledge economy at a public hearing in Washington that will inform the federal government’s annual “Special 301” review of overseas practices that deny adequate and effective intellectual property protection.
http://catalyst.phrma.org/time-to-enforce-the-rules-that-protect-american-ideas-brands-and-inventions

Medicare Monday: Tampering with the Successful Structure of Part D

PhRMA  |  Blog Post

As you know, Medicare Part D is a successful government program coming in well under initial budget projections ($349 billion less than initial 10-year projections, to be exact) and helping to keep costs low for both taxpayers and beneficiaries.
http://catalyst.phrma.org/medicare-monday-tampering-with-the-successful-structure-of-part-d

Medicare Monday: 10 years later, 3 reasons why Part D is a success story

PhRMA  |  Blog Post

Part D costs are $349 billion (or 45 percent) less than initial 10-year projections and spending on Part D is just 10.9 percent of total Medicare spending in 2014.
http://catalyst.phrma.org/medicare-monday-10-years-later-3-reasons-why-part-d-is-a-success-story

Medicare Monday: Medicare Part D Helps Reduce Spending in Parts A and B, Too

PhRMA  |  Blog Post

Phyllis also rely on Part D for access to medicines that help them manage their diabetes.
http://catalyst.phrma.org/medicare-monday-medicare-part-d-helps-reduce-spending-in-parts-a-and-b-too

Five Things You Might Not Know About Medicare Part D

PhRMA  |  Blog Post

According to Congressional Budget Office (CBO) figures, total Part D costs are $349 billion less than initial 10-year projections.
http://catalyst.phrma.org/five-things-you-might-not-know-about-medicare-part-d

PhRMA Statement on Proposed Rule on Medicare Advantage & Part D

PhRMA  |  Press Release

Currently, total Part D costs are 45 percent – or $348 billion – lower than initial projections for 2004-2013.
https://www.phrma.org/press-release/phrma-statement-on-proposed-rule-on-medicare-advantage-and-part-d

New Research Highlights Gaps in Quality Measures for Cancer Patients

PhRMA  |  Blog Post

Avalere analyzed 305 different cancer quality measures and found that even with the volume of available measures, gaps remain.
http://catalyst.phrma.org/new-research-highlights-gaps-in-quality-measures-for-cancer-patients

PDUFA: Still a weird word worth knowing

PhRMA  |  Blog Post

The implementation of PDUFA V began on October 1, 2012.
http://catalyst.phrma.org/pdufa-still-a-weird-word-worth-knowing

Medicare Monday: A Short Video on Medicare Part D

PhRMA  |  Blog Post

  Share your thoughts with us and let us know how the program has helped you or a loved one and be sure to share the video with others who might need a little more information about the program and why it is important. 
http://catalyst.phrma.org/medicare-monday-short-video-medicare-part-d

Fighting blood cancers together at the 2016 Leukemia Ball

PhRMA  |  Blog Post

Today, there are more than 240 medicines in development to treat leukemia, lymphoma and other forms of blood cancer.
http://catalyst.phrma.org/fighting-blood-cancers-together-at-the-2016-leukemia-ball

I'm Not Average: Matt May Have Cancer, but Cancer Doesn’t Have Him

PhRMA  |  Blog Post

One year later his cancer resurfaced and it had spread.
http://catalyst.phrma.org/im-not-average-matt-may-have-cancer-but-cancer-doesnt-have-him

A voice for patients

PhRMA  |  Blog Post

    The CMO position at Merck is unique because of our focus on the patient.
http://catalyst.phrma.org/a-voice-for-patients

Celebrating brighter futures and healthier hearts during American Heart Month

PhRMA  |  Blog Post

Still, heart disease remains the leading cause of death in the United States, taking the lives of one in three Americans and costing society nearly $320 billion each year.
http://catalyst.phrma.org/celebrating-brighter-futures-and-healthier-hearts-during-american-heart-month

You have reviewed the first 300 results out of 429. Each page contains 25 results. You're on page 12.

prev 7 8 9 10 11 12 next